Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies

Author:

Ghazy Ramy Mohamed1ORCID,Sallam Malik23ORCID,Ashmawy Rasha4ORCID,Elzorkany Amira Mohamed5,Reyad Omar Ahmed6,Hamdy Noha Alaa7ORCID,Khedr Heba8,Mosallam Rasha Ali9

Affiliation:

1. Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt

2. Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan

3. Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan

4. Department of Clinical Research, Maamora Chest Hospital, Alexandria 21923, Egypt

5. Egyptian Ministry of Health and Population, Alexandria 21554, Egypt

6. Internal Medicine and Cardiology Clinical Pharmacy Department, Alexandria University Main Hospital, Alexandria 21526, Egypt

7. Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt

8. MDR-TB Center, Maamora Chest Hospital, Alexandria 21912, Egypt

9. Department of Health Administration and Behavioral Science, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt

Abstract

Despite national programs covering the cost of treatment for tuberculosis (TB) in many countries, TB patients still face substantial costs. The end TB strategy, set by the World Health Organization (WHO), calls for “zero” TB households to be affected by catastrophic payments by 2025. This study aimed to measure the catastrophic healthcare payments among TB patients in Egypt, to determine its cost drivers and determinants and to describe the coping strategies. The study utilized an Arabic-validated version of the TB cost tool developed by the WHO for estimating catastrophic healthcare expenditure using the cluster-based sample survey with stratification in seven administrative regions in Alexandria. TB payments were considered catastrophic if the total cost exceeded 20% of the household’s annual income. A total of 276 patients were interviewed: 76.4% were males, 50.0% were in the age group 18–35, and 8.3% had multidrug-resistant TB. Using the human capital approach, 17.0% of households encountered catastrophic costs compared to 59.1% when using the output approach. The cost calculation was carried out using the Egyptian pound converted to the United States dollars based on 2021 currency values. Total TB cost was United States dollars (USD) 280.28 ± 29.9 with a total direct cost of USD 103 ± 10.9 and a total indirect cost of USD 194.15 ± 25.5. The direct medical cost was the main cost driver in the pre-diagnosis period (USD 150.23 ± 26.89 pre diagnosis compared to USD 77.25 ± 9.91 post diagnosis, p = 0.013). The indirect costs (costs due to lost productivity) were the main cost driver in the post-diagnosis period (USD 4.68 ± 1.18 pre diagnosis compared to USD 192.84 ± 25.32 post diagnosis, p < 0.001). The households drew on multiple financial strategies to cope with TB costs where 66.7% borrowed and 25.4% sold household property. About two-thirds lost their jobs and another two-thirds lowered their food intake. Being female, delay in diagnosis and being in the intensive phase were significant predictors of catastrophic payment. Catastrophic costs were high among TB households in Alexandria and showed wide variation according to the method used for indirect cost estimation. The main cost driver before diagnosis was the direct medical costs, while it was the indirect costs, post diagnosis.

Funder

the World Health Organization, East Mediterranean Region

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference53 articles.

1. Global Tuberculosis Report 2020—Reflections on the Global TB burden, treatment and prevention efforts;Chakaya;Int. J. Infect. Dis.,2021

2. Burden of tuberculosis and its association with socio-economic development status in 204 countries and territories, 1990–2019;Xue;Front. Med.,2022

3. The global burden of tuberculosis: Results from the Global Burden of Disease Study 2015;Kyu;Lancet Infect. Dis.,2018

4. The WHO Global Tuberculosis 2021 Report–not so good news and turning the tide back to End TB;Chakaya;Int. J. Infect. Dis.,2022

5. World Bank (2022, January 20). Incidence of Tuberculosis (per 100,000 People). Available online: https://data.worldbank.org/indicator/SH.TBS.INCD.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3